CAC Score (Coronary Calcium): At-Home and Finger-Prick Options, Normal Range, and What Your Number Means

What Is a CAC Score and Why Does It Matter?

A CAC score quantifies calcified atherosclerotic plaque in the coronary arteries using the Agatston method, which multiplies lesion area by a density coefficient on a non-contrast CT scan. Higher scores mean more calcified plaque burden. The test does not require dye, takes under 15 minutes, and exposes patients to roughly 1 to 3 mSv of radiation, about the same as a mammogram.

The Multi-Ethnic Study of Atherosclerosis (MESA, N=6,814) demonstrated that a CAC score of 0 was associated with a 10-year all-cause mortality rate of 3.0 per 1,000 person-years versus 14.8 per 1,000 person-years in those with CAC above 300, establishing calcium scoring as one of the most informative single tests in preventive cardiology. [1]

Why Cardiologists Order This Test

The 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease explicitly states: "In patients at borderline risk (7.5%, 20% 10-year CVD risk), it is reasonable to use the CAC score to guide initiation of statin therapy (Class IIa, Level of Evidence B-NR)." [2] That guideline endorses CAC as the single most useful test to reclassify borderline-risk patients up or down.

How the Agatston Score Is Calculated

Each calcified lesion with a density above 130 Hounsfield units and an area of at least 3 mm² is scored. The density multiplier ranges from 1 (130 to 199 HU) to 4 (above 400 HU). Scores from all coronary segments are summed. Automated software now handles this in seconds, reducing inter-reader variability to under 5% in accredited labs.

What the Number Means Clinically

| CAC Score | Plaque Burden Category | Approximate Relative Risk vs. CAC 0 | |-----------|----------------------|-------------------------------------| | 0 | Absent | Reference (lowest risk) | | 1 to 99 | Mild | 2 to 4× higher event rate | | 100 to 399 | Moderate | 4 to 6× higher | | 400+ | Extensive | 7 to 10× higher |

Data derived from MESA and the Heinz Nixdorf Recall Study (N=4,129). [3]

Can You Get a CAC Score at Home or with a Finger-Prick Test?

No finger-prick or mail-in test directly measures coronary artery calcium. The Agatston score requires CT imaging hardware that cannot be replicated outside a clinical facility. Some direct-to-consumer lab panels market "cardiovascular risk" blood tests, but none produce a CAC score.

Several blood-based biomarkers correlate with atherosclerotic burden and are measurable through at-home mail-in kits. Understanding which tests can and cannot substitute for a CAC scan prevents costly confusion.

Blood Biomarkers Available Through Mail-In Kits

Lipoprotein(a) (Lp(a)): Lp(a) is an independent, largely genetic driver of calcific aortic valve disease and coronary atherosclerosis. A meta-analysis published in the Journal of the American College of Cardiology (pooled N=126,634) found each 50 nmol/L increase in Lp(a) associated with a hazard ratio of 1.11 for coronary heart disease. [4] Lp(a) testing requires a single blood draw and is available through mail-in services. It does not replace CAC but identifies patients who may need a scan even with a low pooled cohort risk score.

High-Sensitivity CRP (hs-CRP): The JUPITER trial (N=17,802) randomized patients with LDL below 130 mg/dL but hs-CRP at or above 2.0 mg/L to rosuvastatin 20 mg versus placebo. Rosuvastatin reduced the primary endpoint (MI, stroke, revascularization, or CV death) by 44% (HR 0.56, 95% CI 0.46 to 0.69, P<0.00001). [5] Elevated hs-CRP with a CAC of 0 places a patient in an intermediate category where watchful management rather than immediate statin initiation may be reasonable.

Apolipoprotein B (ApoB): ApoB reflects the total number of atherogenic particles more accurately than LDL-C alone in patients with metabolic syndrome or hypertriglyceridemia. The ACC/AHA 2018 Cholesterol Guideline designates ApoB above 130 mg/dL as a "risk-enhancing factor" that can tip the decision toward statin therapy. [6] Mail-in ApoB testing is widely available.

What Mail-In Tests Cannot Tell You

Blood biomarkers estimate risk probability. They do not confirm calcified plaque is present or absent. A patient with an ApoB of 145 mg/dL, hs-CRP of 3.2 mg/L, and Lp(a) of 80 nmol/L could have a CAC score anywhere from 0 to 400+. The CT scan answers the anatomical question directly.

A practical decision framework used by the HealthRX medical team:

1. Order mail-in Lp(a), ApoB, hs-CRP, and a standard lipid panel first.
2. If the calculated 10-year ASCVD risk (pooled cohort equations) lands between 5% and 20%, proceed to a CAC scan.
3. If CAC is 0 and no risk-enhancing factors are present, defer statin therapy and re-screen in 5 years.
4. If CAC is 100 or above, initiate high-intensity statin therapy per ACC/AHA Class I guidance.

CAC Score Normal Range and Optimal Values

"Normal" and "optimal" are not the same number for coronary calcium.

A CAC score of 0 is the only value associated with absent calcified plaque. MESA age- and sex-stratified percentile data show the median CAC score in men aged 45 to 54 is 0, with the 75th percentile at approximately 36 and the 90th percentile at approximately 100. [1] In women aged 45 to 54, the median is also 0, with the 75th percentile at approximately 3.

Why 0 Is the Optimal Target

The term "normal" in lab medicine typically means within the population distribution. By that definition, a 60-year-old man with a CAC of 50 might be told he is "normal" because his score falls below the 50th percentile for his age. That framing is misleading. Any detectable calcium confirms the presence of atherosclerotic disease. The Cardiovascular Health Study (N=5,888) showed that participants with CAC above 0 had a significantly higher risk of cardiovascular events regardless of traditional risk factors. [7]

Longevity-focused clinicians increasingly use the phrase "physiologically optimal" to mean CAC of 0, reserving "normal for age" as a separate, less desirable category.

Age- and Sex-Stratified Percentiles from MESA

| Age Group | Sex | 25th %ile | 50th %ile | 75th %ile | 90th %ile | |-----------|-----|-----------|-----------|-----------|-----------| | 45 to 54 | Male | 0 | 0 | 36 | 103 | | 45 to 54 | Female | 0 | 0 | 3 | 32 | | 55 to 64 | Male | 0 | 18 | 143 | 397 | | 55 to 64 | Female | 0 | 0 | 34 | 123 | | 65 to 74 | Male | 3 | 101 | 387 | 795 | | 65 to 74 | Female | 0 | 16 | 130 | 381 |

Source: MESA (N=6,814). [1]

When a Score Above 0 Still Qualifies as Low Risk

A CAC score of 1 to 99 with a low absolute score (below 10) and absence of risk-enhancing factors may not immediately trigger statin therapy. The ACC/AHA 2019 Prevention Guideline notes that "if the CAC score is 1 to 99, it is reasonable to initiate statin therapy, especially in patients aged 55 or older." [2] Below age 55, shared decision-making governs whether to treat.

How to Get a CAC Scan: Practical Steps

A CAC scan does not require a physician referral in most U.S. States. Patients can self-refer at free-standing imaging centers or hospital outpatient radiology departments.

Finding a Scan Near You

The Society of Cardiovascular Computed Tomography maintains a facility locator. The RadiologyInfo patient guide from the Radiological Society of North America describes scan preparation: no caffeine for 4 hours before, no vigorous exercise the morning of the scan, and no metal above the waist. The scan takes under 15 minutes. Results are typically available within 24 to 72 hours.

Cost and Insurance Coverage

Cash-pay pricing ranges from roughly $75 at some hospital systems to $400 at concierge imaging centers. Medicare covers CAC scans only when ordered for specific indications related to atrial fibrillation ablation planning. Most commercial insurers do not cover preventive CAC scanning, though this is slowly changing. The ACC/AHA advocate for broader coverage given the test's ability to downgrade an estimated 14% of borderline-risk patients away from unnecessary statin therapy and upgrade another 14% toward earlier intervention, based on MESA data. [1]

Preparing for the Scan

• Avoid caffeine for 4 hours prior (reduces heart rate variability).
• A resting heart rate below 65 bpm improves image quality; some facilities offer short-acting beta-blockers such as metoprolol 50 mg if needed.
• Remove metal jewelry above the waist.
• No IV contrast is used.

How CAC Scores Guide Statin and Aspirin Decisions

The therapeutic implications of CAC scoring are among the best-validated applications in preventive medicine.

Statin Initiation Thresholds

Per the ACC/AHA 2018 Cholesterol Management Guideline: patients aged 40 to 75 with LDL 70 to 189 mg/dL and a 10-year ASCVD risk of 7.5% to 20% (borderline risk) benefit from a CAC scan before a statin decision. [6] The guideline states: "If CAC is 0, it is reasonable to withhold statin therapy and reassess in 5 to 10 years, as long as higher-risk conditions are absent." If CAC is 100 or above, or 75th percentile or above for age and sex, high-intensity statin therapy (atorvastatin 40 to 80 mg or rosuvastatin 20 to 40 mg) is recommended.

The CAC-Zero Warranty

The concept of a "warranty period" for a CAC score of 0 emerged from MESA follow-up data published in JACC. Patients with CAC 0 at baseline who remained event-free for 10 years had a 15-year cumulative event rate of only 4.5% versus 16.9% in those with CAC above 0 at baseline. [8] This supports deferring repeat scanning for at least 5 years in low-risk individuals with a zero score.

Aspirin in Primary Prevention

The 2022 U.S. Preventive Services Task Force (USPSTF) recommendation on aspirin for primary prevention advises against initiating aspirin in adults 60 and older and recommends individualized decision-making for adults 40 to 59 with a 10-year CVD risk of 10% or higher. [9] A CAC score can sharpen that individual decision. A 52-year-old woman with a CAC of 0 may reasonably forego aspirin; the same woman with a CAC of 250 warrants a serious shared-decision-making conversation about bleeding risk versus benefit.

Emerging Technologies: Could At-Home CAC Testing Ever Exist?

Photon-counting CT scanners, portable cardiac ultrasound, and AI-augmented plain chest radiography are three pathways researchers are exploring.

Photon-Counting CT

Photon-counting detector CT (PCD-CT) scanners such as the Siemens NAEOTOM Alpha have received FDA clearance and produce images at lower radiation doses with higher spatial resolution than conventional energy-integrating CT. [10] They remain hospital-based equipment costing several million dollars, so at-home deployment is not a near-term possibility.

AI-Derived CAC from Chest X-Ray

A 2021 study in JACC Cardiovascular Imaging (N=3,208) trained a deep-learning model to estimate CAC scores from standard posterior-anterior chest radiographs, achieving an area under the curve of 0.79 for detecting CAC above 100. [11] The model is not yet FDA-cleared for clinical use. If cleared, it could theoretically allow CAC estimation from a telehealth-compatible portable X-ray device, reducing cost and radiation versus CT.

Wearable and Microfluidic Biosensors

Several academic groups are developing finger-prick microfluidic panels capable of measuring Lp(a) and ApoB simultaneously with a 15-minute turnaround. These do not measure calcium directly but would allow rapid at-home risk stratification to decide whether a CT scan is warranted. No such device has received FDA 510(k) clearance as of early 2025.

CAC Score in Special Populations

Patients on GLP-1 Receptor Agonists

Semaglutide 2.4 mg (Wegovy) reduced major adverse cardiovascular events by 20% in the SELECT trial (N=17,604, HR 0.80, 95% CI 0.72 to 0.90) in adults with obesity and established cardiovascular disease but without diabetes. [12] Whether this benefit translates to changes in CAC progression is under active investigation. Patients losing significant weight on GLP-1 agents should be rescreened for CAC at baseline before starting, especially if they have never had a scan.

Women and the Underdiagnosis Problem

Women are systematically under-referred for CAC scanning. Data from the Women's Health Initiative (N=1,637 subsample with imaging) show that women with CAC scores of 100 or above had a 10-year coronary heart disease event rate nearly three times higher than women with CAC of 0, yet women remain far less likely than men to receive a referral. [13] A CAC score of 0 in women provides the same strong negative predictive value it does in men.

Patients with Diabetes

The ADA Standards of Medical Care in Diabetes 2024 notes that CAC scoring "may be considered to guide statin intensification in adults with type 2 diabetes aged 40 to 75 at borderline or intermediate cardiovascular risk." [14] Because diabetes itself is classified as a risk-enhancing factor, the threshold for acting on a CAC above 0 is lower in this group.